64.23
price up icon1.28%   0.81
after-market After Hours: 64.27 0.04 +0.06%
loading
Boston Scientific Corp stock is traded at $64.23, with a volume of 12.09M. It is up +1.28% in the last 24 hours and down -9.79% over the past month. Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
See More
Previous Close:
$63.42
Open:
$64.08
24h Volume:
12.09M
Relative Volume:
0.74
Market Cap:
$95.46B
Revenue:
$20.08B
Net Income/Loss:
$2.89B
P/E Ratio:
33.12
EPS:
1.9391
Net Cash Flow:
$3.66B
1W Performance:
+3.95%
1M Performance:
-9.79%
6M Performance:
-35.28%
1Y Performance:
-32.47%
1-Day Range:
Value
$63.90
$64.89
1-Week Range:
Value
$61.44
$65.56
52-Week Range:
Value
$60.59
$109.50

Boston Scientific Corp Stock (BSX) Company Profile

Name
Name
Boston Scientific Corp
Name
Phone
508-683-4000
Name
Address
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Name
Employee
59,000
Name
Twitter
@bostonsci
Name
Next Earnings Date
2026-04-22
Name
Latest SEC Filings
Name
BSX's Discussions on Twitter

Compare BSX vs ABT, SYK, MDT, EW

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
BSX icon
BSX
Boston Scientific Corp
64.23 95.46B 20.08B 2.89B 3.66B 1.9391
ABT icon
ABT
Abbott Laboratories
96.81 168.22B 45.13B 6.28B 7.40B 3.5895
SYK icon
SYK
Stryker Corp
343.32 131.49B 25.12B 3.25B 4.28B 8.3984
MDT icon
MDT
Medtronic Plc
86.19 110.66B 35.48B 4.64B 5.41B 3.582
EW icon
EW
Edwards Lifesciences Corp
80.99 46.69B 6.07B 1.06B 1.34B 1.8063

Boston Scientific Corp Stock (BSX) Upgrades & Downgrades

Date Action Analyst Rating Change
Mar-30-26 Downgrade Raymond James Strong Buy → Outperform
Oct-03-25 Downgrade Erste Group Buy → Hold
Sep-08-25 Upgrade Oppenheimer Perform → Outperform
Jun-16-25 Initiated Leerink Partners Outperform
Apr-16-25 Upgrade Needham Hold → Buy
Jan-10-25 Upgrade Deutsche Bank Hold → Buy
Oct-18-24 Downgrade Needham Buy → Hold
May-30-24 Initiated Goldman Buy
Feb-01-24 Upgrade Mizuho Neutral → Buy
Jul-19-23 Initiated Robert W. Baird Outperform
Jun-30-23 Initiated CL King Buy
May-30-23 Resumed Morgan Stanley Overweight
Mar-29-23 Initiated UBS Buy
Dec-22-22 Initiated Mizuho Neutral
Dec-20-22 Resumed Citigroup Buy
Oct-18-22 Initiated Barclays Overweight
Oct-12-22 Initiated Jefferies Buy
Jul-06-22 Initiated Wolfe Research Outperform
May-27-22 Upgrade Needham Hold → Buy
Apr-13-22 Resumed Truist Buy
Mar-02-22 Resumed BofA Securities Buy
Dec-10-21 Initiated RBC Capital Mkts Outperform
May-26-21 Downgrade Needham Buy → Hold
May-25-21 Initiated Barclays Overweight
Apr-15-21 Initiated Atlantic Equities Overweight
Sep-17-20 Initiated Truist Buy
Sep-11-20 Initiated Wolfe Research Peer Perform
Apr-22-20 Downgrade SVB Leerink Outperform → Mkt Perform
Apr-01-20 Upgrade Goldman Neutral → Buy
Mar-05-20 Initiated Citigroup Buy
Feb-13-20 Initiated Goldman Neutral
Feb-06-20 Resumed BTIG Research Buy
Dec-30-19 Reiterated Cowen Outperform
Dec-19-19 Downgrade Needham Strong Buy → Buy
Sep-05-19 Resumed JP Morgan Overweight
Sep-03-19 Resumed Barclays Overweight
May-13-19 Upgrade Evercore ISI In-line → Outperform
Nov-28-18 Initiated UBS Buy
Oct-16-18 Initiated Barclays Overweight
Oct-02-18 Reiterated Morgan Stanley Overweight
Sep-07-18 Reiterated Needham Strong Buy
Sep-04-18 Upgrade Jefferies Hold → Buy
Jul-06-18 Reiterated Needham Strong Buy
Jun-27-18 Initiated Bernstein Outperform
Apr-26-18 Reiterated Needham Strong Buy
View All

Boston Scientific Corp Stock (BSX) Latest News

pulisher
05:00 AM

ROSEN, THE FIRST FILING FIRM, Encourages Lufax Holding Ltd Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - GlobeNewswire Inc.

05:00 AM
pulisher
04:48 AM

ROSEN, NATIONAL TRIAL LAWYERS, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.

04:48 AM
pulisher
12:34 PM

Boston Scientific Advances Fainting Detection Study With New Wearable Data Initiative - TipRanks

12:34 PM
pulisher
08:07 AM

Boston Scientific Corporation $BSX Position Lifted by Ninety One UK Ltd - MarketBeat

08:07 AM
pulisher
03:48 AM

Asset Management One Co. Ltd. Increases Stock Position in Boston Scientific Corporation $BSX - MarketBeat

03:48 AM
pulisher
03:10 AM

AE Wealth Management LLC Boosts Stake in Boston Scientific Corporation $BSX - MarketBeat

03:10 AM
pulisher
Apr 17, 2026

Boston Scientific Corp Investor Event at the Scientific Session of the American College of Cardiology Transcript - GuruFocus

Apr 17, 2026
pulisher
Apr 17, 2026

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important Deadline in Securities Class ActionBSX - TMX Newsfile

Apr 17, 2026
pulisher
Apr 17, 2026

Boston Scientific Corp. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch

Apr 17, 2026
pulisher
Apr 17, 2026

Boston Scientific Corporation (BSX) Price Target Lowered at Mizuho Ahead of Q1 Medical Device Earnings - Insider Monkey

Apr 17, 2026
pulisher
Apr 17, 2026

Boston Scientific (BSX) Q1 Earnings Preview: What You Should Know Beyond the Headline Estimates - Yahoo Finance

Apr 17, 2026
pulisher
Apr 16, 2026

Boston Scientific: The Company That Never Turned Around - Yahoo

Apr 16, 2026
pulisher
Apr 16, 2026

Analysts Bullish on Boston Scientific (BSX) Amid Expectations for 30% YoY Growth in 2026 - Insider Monkey

Apr 16, 2026
pulisher
Apr 16, 2026

INVESTOR DEADLINE: Boston Scientific Corporation (BSX) Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit - PR Newswire

Apr 16, 2026
pulisher
Apr 16, 2026

BSX Investor Alert: BOSTON SCIENTIFIC CORPORATION Securities Fraud LawsuitInvestors With Losses May Seek to Lead the Class Action After Allegedly Misrepresenting Electrophysiology Procedure Growth - marketscreener.com

Apr 16, 2026
pulisher
Apr 16, 2026

Boston Scientific Corporation $BSX Position Increased by KBC Group NV - MarketBeat

Apr 16, 2026
pulisher
Apr 15, 2026

Boston Scientific (BSX) Outperforms Broader Market: What You Need to Know - Yahoo Finance

Apr 15, 2026
pulisher
Apr 15, 2026

Boston Scientific Corp. stock outperforms competitors on strong trading day - MarketWatch

Apr 15, 2026
pulisher
Apr 15, 2026

BSX Investors Have Opportunity to Lead Boston Scientific Corporation Securities Fraud Lawsuit - ChartMill

Apr 15, 2026
pulisher
Apr 15, 2026

Boston Scientific Corp (BSX-N) Stock Price and News - The Globe and Mail

Apr 15, 2026
pulisher
Apr 15, 2026

Truist cuts Boston Scientific stock price target on Watchman concerns By Investing.com - Investing.com South Africa

Apr 15, 2026
pulisher
Apr 15, 2026

Truist cuts Boston Scientific stock price target on Watchman concerns - Investing.com

Apr 15, 2026
pulisher
Apr 15, 2026

BSX Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026 - marketscreener.com

Apr 15, 2026
pulisher
Apr 15, 2026

Truist Financial Cuts Boston Scientific (NYSE:BSX) Price Target to $90.00 - MarketBeat

Apr 15, 2026
pulisher
Apr 15, 2026

Boston Scientific (BSX) Earnings Expected to Grow: Should You Buy? - Yahoo Finance

Apr 15, 2026
pulisher
Apr 15, 2026

Baird Adjusts Boston Scientific Price Target to $86 From $95, Maintains Outperform Rating - marketscreener.com

Apr 15, 2026
pulisher
Apr 15, 2026

Truist Trims Price Target on Boston Scientific to $90 From $92, Keeps Buy Rating - marketscreener.com

Apr 15, 2026
pulisher
Apr 15, 2026

Boston Scientific invests €75m in Galway site - Business Post

Apr 15, 2026
pulisher
Apr 14, 2026

Boston Scientific Corporation (BSX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - Barchart.com

Apr 14, 2026
pulisher
Apr 14, 2026

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Boston Scientific Corporation of Class Action Lawsuit and Upcoming Deadlines – BSX - ChartMill

Apr 14, 2026
pulisher
Apr 14, 2026

Boston Scientific Corp. stock rises Tuesday, still underperforms market - MarketWatch

Apr 14, 2026
pulisher
Apr 14, 2026

Cardiac Monitoring Devices Market Set for Sustained Growth at 5.17% CAGR Through 2034: DelveInsight | Philips, Medtronic, and Boston Scientific - Barchart.com

Apr 14, 2026
pulisher
Apr 14, 2026

Citi Reiterates Buy rating for Boston Scientific (BSX) - Yahoo Finance

Apr 14, 2026
pulisher
Apr 14, 2026

Boston Scientific Corp. stock (US10117L1017): Is medtech innovation strong enough to unlock new upsi - AD HOC NEWS

Apr 14, 2026
pulisher
Apr 14, 2026

BOSTON SCIENTIFIC CORPORATION (BSX) DEADLINE ALERT Bernstein Liebhard LLP Reminds Boston Scientific Corporation Investors of Upcoming Deadline - TMX Newsfile

Apr 14, 2026
pulisher
Apr 14, 2026

Fund Update: 486,715 BOSTON SCIENTIFIC (BSX) shares added to Bank Pictet & Cie (Europe) AG portfolio - Quiver Quantitative

Apr 14, 2026
pulisher
Apr 14, 2026

BSX Shareholder Alert: Boston Scientific Corporation Securities Class Action Lawsuit Investors With Losses May Join -- The Gross Law Firm - Barchart.com

Apr 14, 2026
pulisher
Apr 14, 2026

RBC Cuts Price Target on Boston Scientific to $105 From $115, Keeps Outperform Rating - marketscreener.com

Apr 14, 2026
pulisher
Apr 13, 2026

Faruqi & Faruqi, LLP Highlights Class Action Against Boston Scientific (BSX) and Upcoming Lead Plaintiff Deadline of May 4, 2026 - marketscreener.com

Apr 13, 2026
pulisher
Apr 13, 2026

Will Boston Scientific (BSX) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance

Apr 13, 2026
pulisher
Apr 13, 2026

Portnoy Law Firm Announces Class Action on Behalf of Boston Scientific Corporation Investors - GlobeNewswire

Apr 13, 2026
pulisher
Apr 12, 2026

BSX SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026 - marketscreener.com

Apr 12, 2026
pulisher
Apr 12, 2026

Sumitomo Mitsui Trust Group Inc. Trims Stock Position in Boston Scientific Corporation $BSX - MarketBeat

Apr 12, 2026
pulisher
Apr 12, 2026

Boston Scientific Corporation $BSX Shares Sold by Robeco Institutional Asset Management B.V. - MarketBeat

Apr 12, 2026
pulisher
Apr 11, 2026

Boston Scientific Corp at TD Cowen Healthcare Conference Transcript - GuruFocus

Apr 11, 2026
pulisher
Apr 11, 2026

Boston Scientific Corporation $BSX Shares Sold by Massachusetts Financial Services Co. MA - MarketBeat

Apr 11, 2026
pulisher
Apr 10, 2026

Boston Scientific Corp. stock (US10117L1017): Is its medtech innovation edge strong enough to drive - AD HOC NEWS

Apr 10, 2026
pulisher
Apr 10, 2026

BSX UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026 - marketscreener.com

Apr 10, 2026
pulisher
Apr 10, 2026

Sowell Financial Services LLC Sells 21,713 Shares of Boston Scientific Corporation $BSX - MarketBeat

Apr 10, 2026
pulisher
Apr 10, 2026

Why Boston Scientific's big dip could be a bigger opportunity - MSN

Apr 10, 2026
pulisher
Apr 10, 2026

BSX Price History for Boston Scientific Corp Stock - Barchart

Apr 10, 2026

Boston Scientific Corp Stock (BSX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
MDT MDT
$86.19
price up icon 0.63%
SYK SYK
$343.32
price up icon 1.46%
EW EW
$80.99
price up icon 2.45%
$74.66
price up icon 1.99%
PHG PHG
$29.70
price up icon 3.74%
Cap:     |  Volume (24h):